Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Dexamethasone for Pediatric Migraine Recurrence
NCT02794441Phase 3Completed
- Sponsor
- Children's Hospital of Eastern Ontario
- Start
- Dec 2016
- Primary completion
- Jun 2017
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in migraine comparing Dexamethasone with Placebo (2 arms). Primary endpoint: Headache Recurrence at 7 days. Started Dec 2016; status: completed.
02
Drugs
dexamethasone
03
Conditions
migraine
Beyond the preview
Go deeper on NCT02794441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02794441.